GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Skystar Bio-Pharmaceutical Co (GREY:SKBI) » Definitions » Pretax Margin %

Skystar Bio-Pharmaceutical Co (Skystar Bio-Pharmaceutical Co) Pretax Margin % : 30.63% (As of Sep. 2014)


View and export this data going back to . Start your Free Trial

What is Skystar Bio-Pharmaceutical Co Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Skystar Bio-Pharmaceutical Co's Pre-Tax Income for the three months ended in Sep. 2014 was $5.62 Mil. Skystar Bio-Pharmaceutical Co's Revenue for the three months ended in Sep. 2014 was $18.35 Mil. Therefore, Skystar Bio-Pharmaceutical Co's pretax margin for the quarter that ended in Sep. 2014 was 30.63%.

The historical rank and industry rank for Skystar Bio-Pharmaceutical Co's Pretax Margin % or its related term are showing as below:


SKBI's Pretax Margin % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 4.06
* Ranked among companies with meaningful Pretax Margin % only.

Skystar Bio-Pharmaceutical Co Pretax Margin % Historical Data

The historical data trend for Skystar Bio-Pharmaceutical Co's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Skystar Bio-Pharmaceutical Co Pretax Margin % Chart

Skystar Bio-Pharmaceutical Co Annual Data
Trend Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 32.21 36.57 31.31 24.95 30.44

Skystar Bio-Pharmaceutical Co Quarterly Data
Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 28.24 30.48 20.56 24.53 30.63

Competitive Comparison of Skystar Bio-Pharmaceutical Co's Pretax Margin %

For the Drug Manufacturers - General subindustry, Skystar Bio-Pharmaceutical Co's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Skystar Bio-Pharmaceutical Co's Pretax Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Skystar Bio-Pharmaceutical Co's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Skystar Bio-Pharmaceutical Co's Pretax Margin % falls into.



Skystar Bio-Pharmaceutical Co Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Skystar Bio-Pharmaceutical Co's Pretax Margin for the fiscal year that ended in Dec. 2013 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2013 )/Revenue (A: Dec. 2013 )
=12.932/42.484
=30.44 %

Skystar Bio-Pharmaceutical Co's Pretax Margin for the quarter that ended in Sep. 2014 is calculated as

Pretax Margin=Pre-Tax Income (Q: Sep. 2014 )/Revenue (Q: Sep. 2014 )
=5.622/18.353
=30.63 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Skystar Bio-Pharmaceutical Co  (GREY:SKBI) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Skystar Bio-Pharmaceutical Co Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Skystar Bio-Pharmaceutical Co's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Skystar Bio-Pharmaceutical Co (Skystar Bio-Pharmaceutical Co) Business Description

Traded in Other Exchanges
N/A
Address
No. 48 Keji Road, 4/F Building B, Chuangye Square, Gaoxin District, Xian, Shaanxi Province, CHN
Skystar Bio-Pharmaceutical Co is a holding company. Through its subsidiaries, it is engaged in the research, development, production, marketing, and sales of veterinary healthcare and medical care products in the People's Republic of China. The company provides individually packaged animal wellness and pharmaceutical products for retail sale. It generates revenue from the sales of four product lines namely, veterinary medications, micro-organism, feed additives, and vaccines. The firm develops, manufactures, packages and distributes vaccines; Western medicines, Traditional Chinese Medicine; topicals, supplements, probiotics; diagnostic kits and animal nutrition supplements for poultry, livestock, marine aquaculture and domesticated pets.

Skystar Bio-Pharmaceutical Co (Skystar Bio-Pharmaceutical Co) Headlines

No Headlines